Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 451 results for "kexin"

Sichuan Kexin Mechanical and Electrical Equipment issues H1 20...

:Sees net profit outlook for H1 of 2015 to increase 171.54 pct to 198.69 pct, or to be about 4 mln yuan to about 4.4 mln yuan.Says the net profit of H1 2014 was 1.4731 mln yuan.Comments that increased orders and decreased expense are the main ... Reuters, 1 month ago
Securities Technology Monitor

New study: 80% of people with established cardiovascular disease significantly underuse statins

/PRNewswire/ --The first of two cholesterol-lowering PCSK9 inhibitors (Proprotein Convertase Subtilisin/Kexin type 9) is expected to be approved by the U.S. Food and Drug Administration (FDA) as early as this week. To guide its utilization ...
 MoneyShow.com1 month ago Masimo Corporation (MASI) Release: New Study: 80% Of People With Established Cardiovascular Disease Significantly Underuse Statins 7/21/2015  ClinicSpace1 month ago Masimo Corporation Release: New Study: 80% Of People With Established Cardiovascular Disease Significantly Underuse Statins  BioSpace1 month ago
[x]  
Monthly Prescribing Reference

PCSK9 inhibitors lower cholesterol, but is cost a concern?

The FDA's approval of the first proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor brought about excitement for some with regards to the effectivenss of the new class of drugs in lowering cholesterol. It also raised concerns about the ...
 Cardiovascular Business1 month ago First-in-Class Cholesterol Drug Approved by FDA  AAPS Pharmceutica1 month ago Study: 80% of Cardiovascular Patients Significantly Underuse Statins  Pharmscope1 month ago Second PCSK9 Inhibitor for High Cholesterol  Monthly Prescribing Reference3 days ago
[x]  
BioSpace

Amgen's PCSK9 Inhibitor, Repatha, Wins EC Nod

The European Commission (EC) granted marketing authorization to Amgen's proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) on July 21, 2015 for the treatment of hypercholesterolemia (heterozygous familial and ...
 BioPharm International1 month ago FDA Approval of Amgen???s Cholesterol Drug Repatha Could Boost Job Growth on East Coast  BioSpace3 days ago FDA Approval of Amgen (AMGN)'s Cholesterol Drug Repatha Could Boost Job Growth on East Coast 8/28/2015  ClinicSpace3 days ago AMGN Gets FDA Nod, AGTC Awaits Data, THLD Initiates Tarloxotinib Trial  RTTNews.com4 days ago
[x]  

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia

Terms of Use The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property ...
 Annals of Internal Medicine4 weeks ago PCSK9 inhibitors: What you should know  Orthopedics Today1 month ago Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)  PharmCast2 months ago
TeleTrader.com

Premarket Biotech Digest: The PCSK9 Race, AbbVie Earnings, Inotek Jumps 200%

Dr De's Opening Thoughts: The Cholesterol Countdown The proprotein convertase subtilisin kexin 9 (PCSK9) enzyme is responsible for increasing LDL-C in the body by reducing a protein that metabolizes cholesterol. PCSK9 inhibitors are monclonal ...
 TeleTrader.com1 month ago
Nasdaq

Magellan Rx Management Offers Key Strategies to Manage PCSK9 Therapies

Payers need innovative solutions for new class of costly drugs SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Following the approval of evolocumab (Repatha; Amgen) by the Food and Drug Administration (FDA) yesterday, Magellan Rx Management, the pharmacy ...
 Nasdaq3 days ago
Xconomy

With FDA OK, Amgen's Heart Drug Faces Rival (And Health Budgets)

[ Updated 8/27/15, 7:28pm, see below .] The new race to fight cholesterol is on. For the second time in a month, the U.S. Food and Drug Administration has approved a drug for people with dangerous levels of cholesterol who aren't getting enough help ...
 Xconomy4 days ago
Ecns.cn

Baosteel braces for shocks

The stand of Baoshan Iron and Steel Co at a metallurgical industry expo in Shanghai. (Photo provided to China Daily) Shanghai-based Baoshan Iron and Steel Co, China's largest listed steelmaker, said on Tuesday that it has taken enough measures ...
 Ecns.cn6 days ago
Pharmacy Times

PCSK9 Inhibitors: Their Likely Place in Hypercholesterolemia Therapy

Michael R. Page, PharmD, RPh PCSK9 inhibitors are a promising new class of drugs for patients with dyslipidemia, but where do they fit in therapy? In early June, FDA expert panels considered 2 new monoclonal antibodies of the treatment of ...
 Pharmacy Times1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less